Galiximab, an anti-CD80 primatized monoclonal antibody, in relapsed Hodgkin lymphoma: Final results of CALGB 50602 Meeting Abstract
| Authors: | Smith, S. M.; Bartiett, N.; Johnson, J. L.; Lister, J.; Cashen, A. F.; Jung, S.; Schoder, H.; Egan, K.; Cheson, B. D. |
| Abstract Title: | Galiximab, an anti-CD80 primatized monoclonal antibody, in relapsed Hodgkin lymphoma: Final results of CALGB 50602 |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 582s |
| Language: | English |
| ACCESSION: | WOS:000208852005059 |
| DOI: | 10.1200/jco.2010.28.15_suppl.8039 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8039 -- S -- Source: Wos |
